Literature DB >> 28924243

Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile.

I Del Giudice1, G M Rigolin2, S Raponi1, L Cafforio1, C Ilari1, J Wang3, M Bordyuh4, A Piciocchi5, M Marinelli1, M Nanni1, S Tavolaro1, M Filetti1, A Bardi2, E Tammiso2, E Volta2, M Negrini2, E Saccenti2, F R Mauro1, D Rossi6, G Gaidano7, A Guarini8, R Rabadan4, A Cuneo2, R Foà1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28924243      PMCID： PMC5898432          DOI： 10.1038/leu.2017.292

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.

Authors:  Panagiotis Baliakas; Michalis Iskas; Anne Gardiner; Zadie Davis; Karla Plevova; Florence Nguyen-Khac; Jitka Malcikova; Achilles Anagnostopoulos; Sharron Glide; Sarah Mould; Kristina Stepanovska; Martin Brejcha; Chrysoula Belessi; Frederic Davi; Sarka Pospisilova; Anastasia Athanasiadou; Kostas Stamatopoulos; David Oscier
Journal:  Am J Hematol       Date:  2014-03       Impact factor: 10.047

2.  Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.

Authors:  C Haferlach; F Dicker; S Schnittger; W Kern; T Haferlach
Journal:  Leukemia       Date:  2007-09-06       Impact factor: 11.528

3.  Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Silvia Rasi; Valeria Spina; Alessio Bruscaggin; Sara Monti; Carmela Ciardullo; Clara Deambrogi; Hossein Khiabanian; Roberto Serra; Francesco Bertoni; Francesco Forconi; Luca Laurenti; Roberto Marasca; Michele Dal-Bo; Francesca Maria Rossi; Pietro Bulian; Josep Nomdedeu; Giovanni Del Poeta; Valter Gattei; Laura Pasqualucci; Raul Rabadan; Robin Foà; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

4.  Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.

Authors:  Robin Foà; Ilaria Del Giudice; Antonio Cuneo; Giovanni Del Poeta; Stefania Ciolli; Francesco Di Raimondo; Francesco Lauria; Emanuele Cencini; Gian Matteo Rigolin; Agostino Cortelezzi; Francesco Nobile; Vincenzo Callea; Maura Brugiatelli; Massimo Massaia; Stefano Molica; Livio Trentin; Rita Rizzi; Giorgina Specchia; Francesca Di Serio; Lorella Orsucci; Achille Ambrosetti; Marco Montillo; Pier Luigi Zinzani; Felicetto Ferrara; Fortunato Morabito; Maria Angela Mura; Silvia Soriani; Nadia Peragine; Simona Tavolaro; Silvia Bonina; Marilisa Marinelli; Maria Stefania De Propris; Irene Della Starza; Alfonso Piciocchi; Alessandra Alietti; Eva Josephine Runggaldier; Enrica Gamba; Francesca Romana Mauro; Sabina Chiaretti; Anna Guarini
Journal:  Am J Hematol       Date:  2014-02-18       Impact factor: 10.047

5.  Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.

Authors:  Claudia Haferlach; Frank Dicker; Tamara Weiss; Susanne Schnittger; Christian Beck; Albert Grote-Metke; Daniel Oruzio; Wolfgang Kern; Torsten Haferlach
Journal:  Genes Chromosomes Cancer       Date:  2010-09       Impact factor: 5.006

6.  Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens.

Authors:  Philip A Thompson; Susan M O'Brien; William G Wierda; Alessandra Ferrajoli; Francesco Stingo; Susan C Smith; Jan A Burger; Zeev Estrov; Nitin Jain; Hagop M Kantarjian; Michael J Keating
Journal:  Cancer       Date:  2015-07-20       Impact factor: 6.860

7.  Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.

Authors:  Xavier C Badoux; Michael J Keating; Xuemei Wang; Susan M O'Brien; Alessandra Ferrajoli; Stefan Faderl; Jan Burger; Charles Koller; Susan Lerner; Hagop Kantarjian; William G Wierda
Journal:  Blood       Date:  2011-01-18       Impact factor: 22.113

8.  Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.

Authors:  Carmen Diana Herling; Marion Klaumünzer; Cristiano Krings Rocha; Janine Altmüller; Holger Thiele; Jasmin Bahlo; Sandra Kluth; Giuliano Crispatzu; Marco Herling; Joanna Schiller; Anja Engelke; Eugen Tausch; Hartmut Döhner; Kirsten Fischer; Valentin Goede; Peter Nürnberg; Hans Christian Reinhardt; Stephan Stilgenbauer; Michael Hallek; Karl-Anton Kreuzer
Journal:  Blood       Date:  2016-05-25       Impact factor: 22.113

9.  Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.

Authors:  Julio Delgado; Itziar Salaverria; Tycho Baumann; Alejandra Martínez-Trillos; Eriong Lee; Laura Jiménez; Alba Navarro; Cristina Royo; Rodrigo Santacruz; Cristina López; Angel R Payer; Enrique Colado; Marcos González; Lluís Armengol; Dolors Colomer; Magda Pinyol; Neus Villamor; Marta Aymerich; Ana Carrió; Dolors Costa; Guillem Clot; Eva Giné; Armando López-Guillermo; Elías Campo; Sílvia Beà
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

10.  Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations.

Authors:  Gonzalo Blanco; Anna Puiggros; Panagiotis Baliakas; Anastasia Athanasiadou; MªDolores García-Malo; Rosa Collado; Aliki Xochelli; María Rodríguez-Rivera; Margarita Ortega; Mª José Calasanz; Elisa Luño; MªTeresa Vargas; Javier Grau; Carolina Martínez-Laperche; Alberto Valiente; José Cervera; Achilles Anagnostopoulos; Eva Gimeno; Eugènia Abella; Evangelia Stalika; Jesús Mª Hernández-Rivas; Francisco José Ortuño; Diego Robles; Ana Ferrer; David Ivars; Marcos González; Francesc Bosch; Pau Abrisqueta; Kostas Stamatopoulos; Blanca Espinet
Journal:  Oncotarget       Date:  2016-12-06
View more
  1 in total

1.  Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

Authors:  Nina Kreuzberger; Johanna Aag Damen; Marialena Trivella; Lise J Estcourt; Angela Aldin; Lisa Umlauff; Maria Dla Vazquez-Montes; Robert Wolff; Karel Gm Moons; Ina Monsef; Farid Foroutan; Karl-Anton Kreuzer; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-07-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.